Literature DB >> 27408124

Atovaquone/Proguanil : A New Drug Combination to Combat Malaria.

M S Mustafa1, V K Agrawal2.   

Abstract

Entities:  

Keywords:  Atovaquone; Malaria; Proguanil

Year:  2011        PMID: 27408124      PMCID: PMC4921596          DOI: 10.1016/S0377-1237(08)80067-6

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


× No keyword cloud information.
  5 in total

1.  Quinine-resistant severe falciparum malaria effectively treated with atovaquone and proguanil hydrochloride combination therapy.

Authors:  Hitoji Uchiyama; Akio Okamoto; Katsuaki Sato; Tomohiro Yamada; Sadatsugu Murakami; Seiichi Yoneda; Yoshihiro Kajita; Tatsuya Tegoshi; Naoki Arizono
Journal:  Intern Med       Date:  2004-07       Impact factor: 1.271

Review 2.  Atovaquone-proguanil for prophylaxis and treatment of malaria.

Authors:  Fawziah Marra; James R Salzman; Mary H H Ensom
Journal:  Ann Pharmacother       Date:  2003-09       Impact factor: 3.154

Review 3.  Treatment of malaria in the United States: a systematic review.

Authors:  Kevin S Griffith; Linda S Lewis; Sonja Mali; Monica E Parise
Journal:  JAMA       Date:  2007-05-23       Impact factor: 56.272

4.  Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.

Authors:  Srivicha Krudsood; Samir N Patel; Nopaddon Tangpukdee; Wipa Thanachartwet; Wattana Leowattana; Karnchana Pornpininworakij; Andrea K Boggild; Sornchai Looareesuwan; Kevin C Kain
Journal:  Am J Trop Med Hyg       Date:  2007-04       Impact factor: 2.345

Review 5.  Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.

Authors:  Kate McKeage; Lesley Scott
Journal:  Drugs       Date:  2003       Impact factor: 9.546

  5 in total
  1 in total

1.  Artemisinin-naphthoquine combination: A directly observed treatment option in malaria.

Authors:  M S Mustafa; V Rastogi
Journal:  Med J Armed Forces India       Date:  2016-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.